Diagnostic Approach and Management of Clostridium difficile Infection
), Achmad Fauzi(2),
(1) Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo General National Hospital, Jakarta
(2) Division of Gastroenterologi, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo General National Hospital, Jakarta
Corresponding Author
Abstract
Clostridium difficile infection (CDI) was first viewed as a nosocomial infection as it is associated with antibiotics administration. But since antibiotics are more frequently to be prescribed in the community setting, clinicians should investigate the probability of all antibiotics-associated diarrhea as CDI.
Diagnostic of CDI should be conducted cautiously as the manifestation of CDI varies from asymptomatic to fatal consequences and is associated with morbidity, mortality, recurrence risk, outbreak possibility, and low quality of life. Management of this infection should include infection prevention and control, stopping the offending antibiotics, and administration of specific antimicrobials.
Clinicians should also recognize the risk of recurrence and the higher probability of less efficacious specific antimicrobials in each episode of recurrence.
Keywords
References
Czepiel J, Dróżdż M, Pituch H, Kuijper EJ, Perucki W,
Mielimonka A, et al. Clostridium difficile infection: review.
Eur J Clin Microbiol Infect Dis. 2019;38:1211–21.
Martin JSH, Monaghan TM, Wilcox MH. Clostridium
difficile infection: epidemiology, diagnosis and understanding
transmission. Nat Rev Gastroenterol Hepatol. 2016;13:206–
Smits WK, Lyras D, Lacy DB, Wilcox MH, Kuijper EJ.
Clostridium difficile infection. Nat Rev Dis Primers.
;2:16020.
van Prehn J, Reigadas E, Vogelzang EH, Bouza E, Hristea A,
Guery B, et al. European Society of Clinical Microbiology and
Infectious Diseases: 2021 update on the treatment guidance
document for Clostridioides difficile infection in adults. Clin
Microbiol Infect. 2021;27:S1–21.
Nelson RL, Suda KJ, Evans CT. Antibiotic treatment for
Clostridium difficile-associated diarrhoea in adults. Cochrane
Database Syst Rev. 2017;3:CD004610.
Khanna S, Pardi DS, Kelly CR, Kraft CS, Dhere T, Henn MR,
et al. A novel microbiome therapeutic increases gut microbial
diversity and prevents recurrent Clostridium difficile infection.
J Infect Dis. 2016;214:173–81.
Kee VR. Clostridium difficile infection in older adults:
a review and update on its management. Am J Geriatr
Pharmacother. 2011;10:14–24.
Gale AR, Wilson M. Clostridioides difficile. In: Graham A,
Carlberg DJ, eds. Gastrointestinal Emergencies: Evidence-
Based Answers to Key Clinical Questions. 1st ed. New York:
Springer Cham. 2019:I.p.353–6.
Sartelli M, di Bella S, McFarland LV, Khanna S, Furuya-
Kanamori L, Abuzeid N, et al. 2019 update of the WSES
guidelines for management of Clostridioides (Clostridium)
difficile infection in surgical patients. World J Emerg Surg.
;14:8.
Johnson S, Lavergne V, Skinner AM, Gonzales-Luna AJ,
Garey KW, Kelly CP, et al. Clinical practice guideline by the
Infectious Diseases Society of America (IDSA) and Society for
Healthcare Epidemiology of America (SHEA): 2021 focused
update guidelines on management of Clostridioides difficile
infection in adults. Clin Infect Dis. 2021;73:e1029–44.
McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll
KC, Coffin SE, et al. Clinical practice guidelines for
Clostridium difficile infection in adults and children: 2017
update by the Infectious Diseases Society of America (IDSA)
and Society for Healthcare Epidemiology of America (SHEA).
Clin Infect Dis. 2018;66:e1–48.
Simor AE. Diagnosis, management, and prevention of
Clostridium difficile infection in long-term care facilities: a
review. J Am Geriatr Soc 2010;58:1556–64.
Cleary RK. Clostridium difficile-associated diarrhea and
colitis: clinical manifestations, diagnosis, and treatment. Dis
Colon Rectum. 1998;41:1435–49.
Khan FY, Elzouki AN. Clostridium difficile infection: a review
of the literature. Asian Pac J Trop Med. 2014;7S1(S1):S6–13.
Mullish BH, Quraishi MN, Segal JP, McCune VL, Baxter M,
Marsden GL, et al. The use of faecal microbiota transplant
as treatment for recurrent or refractory Clostridium difficile
infection and other potential indications: joint British Society
of Gastroenterology (BSG) and Healthcare Infection Society
(HIS) guidelines. Gut. 2018;0:1-22
Article Metrics
Abstract View
: 239 times
Download : 141 times
PDF Download : 130 times
DOI: 10.24871/2432023250
Refbacks
- There are currently no refbacks.
